1Martin TJ, Moseley JM. Mechanisms in the skeletal complications of breast cancer. Endocr Relat Cancer, 2000, 7(4): 271-284.
2Seely JC, Boorman GA. Marrwnary gland and specialized sebaceous glands. In: Maronpot RR, Boorman GA, Gaul BW, eds. Pathology of the mouse. Vienna, IL: Cache River Press, 1999. 613-636.
3Stoica G, Koestner A, Capen CC. Neoplasms induced with high single doses of N-ethyl-N-nitrosourea in 30-day-old Sprague-Dawley rats, with special emphasis on mammary neoplasia. Anticancer Ras,1984,4: 5-12.
4Shen Q, Brown PH. Transgenic mouse models for the prevention of breast cancer. Mutat Res, 2005, 576: 93-110.
5Rosol TJ, Tannehill-Gregg SH, LeRoy BE, et al. Animal models of bone metastasis. Cancer, 2003, 97: 748-757.
6Burdall SE, Hanby AM, Lansdown MR, et al. Breast cancer cell lines: friend or foe? Breast Cancer Res, 2003, 5: 89-95.
7Clarke R. Human breast cancer cell line xenografts as models of breast cancer-The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. Breast Cancer Res Treat,1996, 39: 69-86.
8Shi HY, Zhang W, Liang R, et al. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model.Cancer Res, 2001, 61: 6945-6951.
9Murphy BO, Joshi S, Kessinger A, et al. A murine model of bone marrow micrometastasis in breast cancer. Clin Exp Metastasis,2002, 19(7): 561-569.
10Yoneda T, Williams PJ, Hiraga T, et al. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res, 2001, 16:1486-1495.
